Literature DB >> 15690684

Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-20021).

R R Reinert1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15690684     DOI: 10.1080/1120009x.2004.11782401

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


× No keyword cloud information.
  5 in total

1.  Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.

Authors:  Ralf René Reinert; Michael R Jacobs; Peter C Appelbaum; Saralee Bajaksouzian; Soraia Cordeiro; Mark van der Linden; Adnan Al-Lahham
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study.

Authors:  Nguyen Quynh Hoa; Nguyen V Trung; Mattias Larsson; Bo Eriksson; Ho D Phuc; Nguyen Tk Chuc; Cecilia Stalsby Lundborg
Journal:  BMC Infect Dis       Date:  2010-03-31       Impact factor: 3.090

4.  Azithromycin use in paediatrics: A practical overview.

Authors:  Philippe Ovetchkine; Michael J Rieder
Journal:  Paediatr Child Health       Date:  2013-06       Impact factor: 2.253

Review 5.  Benefit-risk assessment of telithromycin in the treatment of community-acquired pneumonia.

Authors:  Steven D Brown
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.